| (1) |
Hashimoto H. Zur Kenntniss der lymphomatosen Veranderung derSchilddruse(Struma
lymphomatosa). Arch Klin Chir 1912; 97: 219-48. |
| (2) |
Roitt IM, Doniach D, Campbell PN, Hudson RV. Auto-antibodies in Hashimoto's
disease (lymphadenoid goitre). Lancet 1956; 2: 820-1. |
| (3) |
Nagataki S. The concept of Hashimoto disease. In: Nagataki S, Mori T,
Torizuka K, eds. 80 Years of Hashimoto disease. Amsterdam: Elsevier Sci-ence,
1993: 539-45. |
| (4) |
Costa A, Torchio B, Zoppetti G, Feyless E. What is meant today by Ha-shimoto's
thyroiditis? J Endocrinol Invest 1989; 12: 355-6. |
| (5) |
Volp? R. Autoimmune thyroiditis. In: Braverman LE, Utiger RD, eds. Werner
and Ingbar's the thyroid: a fundamental and clinical text. 6th ed. Philadelphia:
J.B. Lippincott, 1991: 921-33. |
| (6) |
Hay ID. Thyroiditis: a clinical update. Mayo Clin Proc 1985; 60: 836-43. |
| (7) |
Livolsi VA. The pathology of autoimmune thyroid disease: a review. Thyroid
1994; 4: 333-9. |
| (8) |
Vickery AL, Hamblin E Jr. Struma lymphomatosa (Hashimoto's thy-roiditis):
observations on repeated biopsies in sixteen patients. N Engl J Med 1961;
264: 226-9. |
| (9) |
Hayashi Y, Tamai H, Fukata S, et al. A long term clinical, immunological,
and histological follow-up study of patients with goitrous chronic lym-phocytic
thyroiditis. J Clin Endocrinol Metab 1985; 61: 1172-8. |
| (10) |
Weetman AP, McGregor AM. Autoimmune thyroid disease: further developments
in our understanding. Endocr Rev 1994; 15: 788-830. |
| (11) |
Dayan CM, Londei M, Corcoran AE, et al. Autoantigen recognition by thyroid-infiltrating
T cells in Graves' disease. Proc Natl Acad Sci USA 1991; 88: 7415-9. |
| (12) |
Davies TF, Martin A, Concepcion ES, Graves P, Cohen L, Ben-Nun A. Evidence
of limited variability of antigen receptors on intrathyroidal T cells in
autoimmune thyroid disease. N Engl J Med 1991; 325: 238-44. |
| (13) |
McIntosh RS, Tandon N, Pickerill AP, Davies R, Barnett D, Weetman AP.
IL-2 receptor-positive intrathyroidal lymphocytes in Graves' disease: analysis
of V alpha transcript microheterogeneity. J Immunol 1993; 151: 3884-93. |
| (14) |
Valtonen VV, Ruutu P, Varis K, Ranki M, Malkamaki M, Makela PH. Serological
evidence for the role of bacterial infections in the pathogenesis of thyroid
diseases. Acta Med Scand 1986; 219: 105-11. |
| (15) |
Tomer Y, Davies TF. Infection, thyroid disease, and autoimmunity. Endocr
Rev 1993; 14: 107-20. |
| (16) |
Drabick JJ, Horning VL, Lennox JL, et al. A retrospective analysis of
diseases associated with indeterminate HIV Western blot patterns. Mil Med
1991; 156: 93-6. |
| (17) |
Volpe R. A perspective on human autoimmune thyroid disease: is there an
abnormality of the target cell which predisposes to the disorder? Autoimmunity
1992; 13: 3-9. |
| (18) |
Hanafusa T, Pujol-Borrell R, Chiovato L, Russell RCG, Doniach D, Bottazzo
GF. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease:
relevance for autoimmunity. Lancet 1983; 2: 1111-5. |
| (19) |
Todd I, Pujol-Borrell R, Hammond LJ, Bottazzo GF, Feldman M. Interferon-gamma
induces HLA-DR expression by thyroid epithelium. Clin Exp Immunol 1985;
61: 265-73. |
| (20) |
Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldmann M. Role of ab-errantHLA-DR
expression and antigen presentation in induction of endo-crine autoimmunity.
Lancet 1983; 2: 1115-9. |
| (21) |
Londei M, Bottazzo GF, Feldmann M. Human T-cell clones from au-toimmune
thyroid glands: specific recognition of autologous thyroid cells. Science
1985; 228: 85-9. |
| (22) |
Tandon N, Metcalfe RA, Barnett D, Weetman AP. Expression of the costimulatory
molecule B7/BB1 in autoimmune thyroid disease. Q J Med 1994; 87: 231-6. |
| (23) |
Czarnocka B, Ruf J, Ferrand M, Carayon P, Lissitzky S. Purification of
the human thyroid peroxidase and its identification as the microsomal antigen
involved in autoimmune thyroid disease. FEBS Lett 1985; 190: 147-52. |
| (24) |
Dumont JE, Roger PP, Ludgate M. Assays for thyroid growth immu-noglobulins
and their clinical implications: methods, concepts and miscon-ceptions.
Endocr Rev 1987; 8: 448-52. |
| (25) |
Del Prete GF, Vercelli D, Tiri A, et al. In vivo activated cytotoxic T
cells in the thyroid infiltrate of patients with Hashimoto's thyroiditis.
Clin Exp Immunol 1986; 65: 140-7. |
| (26) |
Kohno Y, Yamaguchi F, Saito K, Niimi H, Nishikawa T, Hosoya T. Anti-thyroid
peroxidase antibodies in sera from healthy subjects and from patients with
chronic thyroiditis: differences in the ability to inhibit thyroid peroxidase
activities. Clin Exp Immunol 1991; 85: 459-63. |
| (27) |
Khoury EL, Hammond L, Bottazzo GF, Doniach D. Presence of the organ-specific
ﾔmicrosomal' autoantigen on the surface of human thyroid cells in culture:
its involvement in complement-mediated cytotoxicity. Clin Exp Immunol 1981;
45: 316-28. |
| (28) |
Bogner U, Kotulla P, Peters H, Schleusener H. Thyroid peroxidase/microsomal
antibodies are not identical with thyroid cytotoxic antibodies in autoimmune
thyroiditis. Acta Endocrinol 1990; 123: 431-7. |
| (29) |
Chiovato L, Bassi P, Santini F, et al. Antibodies producing comple-mentmediated
thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis.
J Clin Endocrinol Metab 1993; 77: 1700-5. |
| (30) |
Weetman AP, Cohen SB, Oleesky DA, Morgan BP. Terminal comple-ment complexes
and C1/C1 inhibitor complexes in autoimmune thyroid disease. Clin Exp Immunol
1989; 77: 25-30. |
| (31) |
Konishi J, Kasagi K, Iida Y. Thyroid stimulation blocking antibodies ?
an overview. In: Nagataki S, Mori T, Torizuka K, eds. 80 Years of Ha-shimoto
disease. Amsterdam: Elsevier Science, 1993: 573-7. |
| (32) |
Tamaki H, Amino N, Kimura M, Hidaka Y, Takeoka K, Miyai K. Low prevalence
of thyrotropin receptor antibody in primary hypothyroidism in Japan. J Clin
Endocrinol Metab 1990; 71: 1382-6. |
| (33) |
Takasu N, Yamada T, Takasu M, et al. Disappearance of thyrotropin-blocking antibodies
and spontaneous recovery from hypothyroidism in au-toimmune thyroiditis.
N Engl J Med 1992; 326: 513-8. |
| (34) |
Phillips D, McLachlan S, Stephenson A, et al. Autosomal dominant transmission
of autoantibodies to thyroglobulin and thyroid peroxidase. J Clin Endocrinol
Metab 1990; 70: 742-6. |
| (35) |
Phillips D, Prentice L, Upadhyaya M, et al. Autosomal dominant in-heritance of
autoantibodies to thyroid peroxidase and thyroglobulin ﾑ studies in families
not selected for autoimmune thyroid disease. J Clin Endocrinol Metab 1991;
72: 973-5. |
| (36) |
Roitt IM, Doniach D. A reassessment of studies on the aggregation of thyroid
autoimmunity in families of thyroiditis patients. Clin Exp Immunol 1967;
2: Suppl: 727-36. |
| (37) |
Chopra IJ, Solomon DH, Chopra U, Yoshihara E, Terasaki PI, Smith F. Abnormalities
in thyroid function in relatives of patients with Graves' disease and Hashimoto's
thyroiditis: lack of correlation with inheritance of HLA-B8. J Clin Endocrinol
Metab 1977; 45: 45-54. |
| (38) |
Honda K, Tamai J, Morita T, Kuma K, Nishimura Y, Sasazuki T. Ha-shimoto's
thyroiditis and HLA in Japanese. J Clin Endocrinol Metab 1989; 69: 1268-73. |
| (39) |
Tamai H, Kimura A, Dong R-P, et al. Resistance to autoimmune thyroid disease
is associated with HLA-DQ. J Clin Endocrinol Metab 1994; 78: 94-7. |
| (40) |
Roman SH, Greenberg D, Rubinstein P, Wallenstein S, Davies TF. Ge-netics
of autoimmune thyroid disease: lack of evidence for linkage to HLA within
families. J Clin Endocrinol Metab 1992; 74: 496-503. |
| (41) |
Kennedy RL, Jones TH, Cuckle HS. Down's syndrome and the thyroid. Clin
Endocrinol (Oxf) 1992; 37: 471-6. |
| (42) |
Ewins DL, Rossor MN, Butler J, Roques PK, Mullan MJ, McGregor AM. Association
between autoimmune thyroid disease and familial Alz-heimer's disease. Clin
Endocrinol (Oxf) 1991; 35: 93-6. |
| (43) |
de Kerdanet M, Lucas J, Lemee F, Lecornu M. Turner's syndrome with X-isochromosome
and Hashimoto's thyroiditis. Clin Endocrinol(Oxf) 1994;41:673-6. |
| (44) |
Laurberg P. Iodine intake ﾑ what are we aiming at? J Clin Endocrinol Metab
1994; 79: 17-9. |
| (45) |
Harach HR, Escalante DA, Onativia A, Outes JL, Day ES, Williams ED. Thyroid
carcinoma and thyroiditis in an endemic goitre region before and after iodine
prophylaxis. Acta Endocrinol (Copenh) 1985; 108: 55-60. |
| (46) |
Boukis MA, Koutras DA, Souvatzoglou A, Evangelopoulou A, Vrontakis M,
Moulopoulos SD. Thyroid hormone and immunological studies in endemic goiter.
J Clin Endocrinol Metab 1983; 57: 859-62. |
| (47) |
Chow CC, Phillips DI, Lazarus JH, Parkes AB. Effect of low dose iodide
supplementation on thyroid function in potentially susceptible sub-jects:
are dietary iodide levels in Britain acceptable? Clin Endocrinol (Oxf) 1991;
34: 413-6. |
| (48) |
Konno N, Makita H, Yuri K, Iizuka N, Kawasaki K. Association be-tween
dietary iodine intake and prevalence of subclinical hypothyroidism in the
coastal regions of Japan. J Clin Endocrinol Metab 1994; 78: 393-7. |
| (49) |
Braverman LE, Ingbar SH, Vagenakis AG, Adams L, Maloof F. Enhanced susceptibility
to iodide myxedema in patients with Hashimoto's disease. J Clin Endocrinol
Metab 1971; 32: 515-21. |
| (50) |
Trip MD, Wiersinga W, Plomp TA. Incidence, predictability, and pathogenesis
of amiodarone-induced thyrotoxicosis and hypothyroidism. Am J Med 1991;
91: 507-11. |
| (51) |
Emerson CH, Dysno WL, Utiger RD. Serum thyrotropin and thyroxine concentrations
in patients receiving lithium carbonate. J Clin Endo-crinol Metab 1973;
36: 338-46. |
| (52) |
Lazarus JH, John R, Bennie EH, Chalmers RJ, Crockett G. Lithium therapy
and thyroid function: a long-term study. Psychol Med 1981; 11: 85-92. |
| (53) |
Burman P, Totterman TH, Oberg K, Karlsson FA. Thyroid autoimmu-nity in
patients on long term therapy with leukocyte-derived interferon. J Clin
Endocrinol Metab 1986; 63: 1086-90. |
| (54) |
Sauter NP, Atkins MB, Mier JW, Lechan RM. Transient thyrotoxicosis and
persistent hypothyroidism due to acute autoimmune thyroiditis after interleukin-2
and interferon-alpha therapy for metastatic carcinoma: a case report. Am
J Med 1992; 92: 441-4. |
| (55) |
Gisslinger H, Gilly B, Woloszczuk W, et al. Thyroid autoimmunity and hypothyroidism
during long-term treatment with recombinant interferon-alpha. Clin Exp Immunol
1992; 90: 363-7. |
| (56) |
Imagawa A, Itoh N, Hanafusa T, et al. Autoimmune endocrine disease induced
by recombinant interferon-alpha therapy for chronic active type C hepatitis.
J Clin Endocrinol Metab 1995; 80: 922-6. |
| (57) |
Atkins MB, Mier JW, Parkinson DR, Gould JA, Berkman EM, Kaplan MM. Hypothyroidism
after treatment with interleukin-2 and lymphokine-activated killer cells.
N Engl J Med 1988; 318: 1557-63. |
| (58) |
Hoekman K, von Blomberg-van der Flier BME, Wagstaff J, Drexhage HA, Pinedo
HM. Reversible thyroid dysfunction during treatment with GM-CSF. Lancet
1991; 338: 541-2. |
| (59) |
Watanabe U, Hashimoto E, Hisamitsu T, Obata H, Hayashi N. The risk factors
for development of thyroid disease during interferon-alpha therapy for chronic
hepatitis C. Am J Gastroenterol 1994; 89: 399-403. |
| (60) |
Bhakri H, Sriskandan K, Davis T, Pettingale K, Tee D. Recombinant gamma
interferon and autoimmune thyroid disease. Lancet 1985; 2: 457. |
| (61) |
Williams ED, Doniach I. The post-mortem incidence of focal thyroiditis.
J Pathol Bacteriol 1962; 83: 255-64. |
| (62) |
Okayasu I, Hara Y, Nakamura K, Rose NR. Racial and age-related dif-ferences
in incidence and severity of focal autoimmune thyroiditis. Am J Clin Pathol
1994; 101: 698-702. |
| (63) |
Mariotti S, Caturegli P, Piccolo P, Barbesino G, Pinchera A. Antithy-roid
peroxidase autoantibodies in thyroid diseases. J Clin Endocrinol Metab 1990;
71: 661-9. |
| (64) |
Amino N, Hagen SR, Yamada N, Refetoff S. Measurement of circulat-ing thyroid
microsomal antibodies by the tanned red cell haemagglutina-tion technique:
its usefulness in the diagnosis of autoimmune thyroid dis-eases. Clin Endocrinol
(Oxf) 1976; 5: 115-25. |
| (65) |
Tunbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease
in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977; 7: 481-93. |
| (66) |
Barbato MP. Thyroid autoantibodies in an Australian community. Med J Aust
1978; 2: 511-2. |
| (67) |
Mariotti S, Sansoni P, Barbesino G, et al. Thyroid and other organ-spe-cific
autoantibodies in healthy centenarians. Lancet 1992; 339: 1506-8. |
| (68) |
Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and
follow-up of abnormal thyrotrophin (TSH) concentrations in the eld-erly
in the United Kingdom. Clin Endocrinol (Oxf) 1991; 34: 77-83. |
| (69) |
Bagchi N, Brown TR, Parish RF. Thyroid dysfunction in adults over age
55 years: a study in an urban US community. Arch Intern Med 1990; 150: 785-7. |
| (70) |
Ladenson PW, Wilson WC, Gardin J, et al. Relationship of subclinical hypothyroidism
to cardiovascular risk factors and disease in an elderly pop-ulation. Thyroid
1994; 4: Suppl 1:S-18. abstract. |
| (71) |
Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P. The aging
thyroid: thyroid deficiency in the Framingham Study. Arch Intern Med 1985;
145: 1386-8. |
| (72) |
Vanderpump MPJ, Tunbridge WMG, French JM, et al. The incidence of thyroid
disorders in the community: a twenty-year follow-up of the Whickham Survey.
Clin Endocrinol (Oxf) 1995; 43: 55-68. |
| (73) |
Doniach D, Bottazzo GF, Russell RCG. Goitrous autoimmune
thyroiditis(Hashimoto's disease). Clin Endocrinol Metab 1979; 8: 63-80. |
| (74) |
Tsuboi K, Yuasa R, Tanaka Y, Ueshiba H, Takeda S, Ito K. Incidence of
thyroid atrophy in patients with Hashimoto thyroiditis. In: Nagataki S,
Mori T, Torizuka K, eds. 80 Years of Hashimoto disease. Amsterdam: Elsevier
Science, 1993: 69-72. |
| (75) |
Rallison ML, Dobyns BM, Meikle AW, Bishop M, Lyon JL, Stevens W. Natural
history of thyroid abnormalities: prevalence, incidence, and re-gression
of thyroid diseases in adolescents and young adults. Am J Med1991; 91: 363-70.
[Erratum, Am J Med 1992; 92: 582.] |
| (76) |
Katz SM, Vickery AL Jr. The fibrous variant of Hashimoto's thyroiditis.
Hum Pathol 1974; 5: 161-70. |
| (77) |
Sostre S, Reyes MM. Sonographic diagnosis and grading of Hashimo-to's
thyroiditis. J Endocrinol Invest 1991; 14: 115-21. |
| (78) |
Nordmeyer JP, Shafeh TA, Heckmann C. Thyroid sonography in au-toimmune
thyroiditis: a prospective study on 123 patients. Acta Endocrinol(Copenh)
1990; 122: 391-5. |
| (79) |
Zimmerman RS, Brennan MD, McConahey WM, Goellner JR,Gharib H. Hashimoto's
thyroiditis: an uncommon cause of painful thyroid unresponsive to corticosteroid
therapy. Ann Intern Med 1986; 104: 355-7. |
| (80) |
Nordyke RA, Gilbert FI Jr, Miyamoto LA, Fleury KA. The superiority of
antimicrosomal over antithyroglobulin antibodies for detecting Hashi-moto's
thyroiditis. Arch Intern Med 1993; 153: 862-5. |
| (81) |
Ramtoola S, Maisey MN, Clark SEM, Fogelman I. The thyroid scan in Hashimoto's
thyroiditis: the great mimic. Nucl Med Commun 1988; 9: 639-45. |
| (82) |
Hypothyroidism and enlarging thyroid mass in a young woman. Am J Med 1993;
95: 534-41. |
| (83) |
Ravinsky E, Safneck JR. Differentiation of Hashimoto's thyroiditis from
thyroid neoplasms in fine needle aspirates. Acta Cytol 1988; 32: 854-61. |
| (84) |
Tani E, Skoog L. Fine needle aspiration cytology and immunocyto-chemistry
in the diagnosis of lymphoid lesions of the thyroid gland. Acta Cytol 1989;
33: 48-52. |
| (85) |
Tunbridge WMG, Brewis M, French JM, et al. Natural history of au-toimmune
thyroiditis. BMJ 1981; 282: 258-62. |
| (86) |
Geul KW, van Sluisveld ILL, Grobbee DE, et al. The importance of thyroid
microsomal antibodies in the development of elevated serum TSH in middle-aged
women: associations with serum lipids. Clin Endocrinol(Oxf) 1993; 39: 275-80. |
| (87) |
Rosenthal MJ, Hunt WC, Garry PJ, Goodwin JS. Thyroid failure in the elderly:
microsomal antibodies as discriminant for therapy. JAMA 1987; 258: 209-13. |
| (88) |
Lazarus JH, Burr ML, McGregor AM, et al. The prevalence and pro-gression
of autoimmune thyroid disease in the elderly. Acta Endocrinol(Copenh) 1984;
106: 199-202. |
| (89) |
Gordin A, Lamberg B-A. Spontaneous hypothyroidism in symptomless autoimmune
thyroiditis: a long-term follow-up study. Clin Endocrinol(Oxf) 1981; 15:
537-43. |
| (90) |
Kurihara H, Sasaki J, Takamatsu M. Twenty cases with Hashimoto dis-ease
changing to Graves' disease. In: Nagataki S, Mori T, Torizuka K, eds. 80
Years of Hashimoto disease. Amsterdam: Elsevier Science, 1993: 249-53. |
| (91) |
Sugrue D, McEvoy M, Feely J, Drury MI. Hyperthyroidism in the land of
Graves: results of treatment by surgery, radio-iodine and carbimazole in
837 cases. Q J Med 1980; 49: 51-61. |
| (92) |
Wood LC, Ingbar SH. Hypothyroidism as a late sequela in patients with
Graves' disease treated with antithyroid agents. J Clin Invest 1979; 64:
1429-36. |
| (93) |
Hedley AJ, Young RE, Jones SJ, Alexander WD, Bewsher PD. Antithy-roid
drugs in the treatment of hyperthyroidism of Graves' disease: long-term
follow-up of 434 patients. Clin Endocrinol (Oxf) 1989; 31: 209-18. |
| (94) |
Kato I, Tajima K, Suchi T, et al. Chronic thyroiditis as a risk factor
for B-cell lymphoma in the thyroid gland. Jpn J Cancer Res 1985; 76: 1085-90. |
| (95) |
Matsuzuka F, Miyauchi A, Katayama S, et al. Clinical aspects of pri-mary
thyroid lymphoma: diagnosis and treatment based on our experience of 119
cases. Thyroid 1993; 3: 93-9. |
| (96) |
Holm LE, Blomgren H, L?hagen T. Cancer risks in patients with chronic
lymphocytic thyroiditis. N Engl J Med 1985; 312: 601-4. |
| (97) |
Aozasa K, Inoue A, Tajima K, Miyauchi A, Matsuzuka F, Kuma K. Ma-lignant
lymphomas of the thyroid gland: analysis of 79 patients with em-phasis on
histologic prognostic factors. Cancer 1986; 58: 100-4. |
| (98) |
Maurer R, Taylor CR, Terry R, Lukes RJ. Non-Hodgkin lymphomas of the thyroid:
a clinico-pathological review of 29 cases applying the Luke-Collins classification
and an immunoperoxidase method. Virchows Arch A Pathol Anat Histol 1979;
383: 293-317. |
| (99) |
Oertel JE, Heffess CS. Lymphoma of the thyroid and related disorders.
Semin Oncol 1987; 14: 333-42. |
| (100) |
Stagnaro-Green A, Roman SH, Cobin RH, el-Harazy E, Alvarez-Marfany M,
Davies TF. Detection of at-risk pregnancy by means of highly sensitive assays
for thyroid autoantibodies. JAMA 1990; 264: 1422-5. |
| (101) |
Pratt D, Novotny M, Kaberlein G, Dudkiewicz A, Gleicher N. Antithyroid
antibodies and the association with non-organ specific anti-bodies in recurrent
pregnancy loss. Am J Obstet Gynecol 1993; 168: 837-41. |
| (102) |
Tamaki H, Amino N, Aozasa M, et al. Effective method for prediction of
transient hypothyroidism in neonates born to mothers with chronic thyroiditis.
Am J Perinatol 1989; 6: 296-303. |
| (103) |
Stagnaro-Green A. Postpartum thyroiditis: prevalence, etiology and clinical
implications. Thyroid Today 1993; 16: 1-11. |
| (104) |
Vargas MT, Briones-Urbina R, Gladman D, Papsin FR, Walfish PG. Antithyroid
microsomal autoantibodies and HLA-DR5 are associated with postpartum thyroid
dysfunction: evidence supporting an autoimmune pathogenesis. J Clin Endocrinol
Metab 1988; 67: 327-33. |
| (105) |
Hayslip CC, Fein HG, O'Donnell VM, Friedman DS, Klein TA, Smallridge RC.
The value of serum antimicrosomal antibody testing in screening for symptomatic
postpartum thyroid dysfunction. Am J Obstet Gynecol 1988; 159: 203-9. |
| (106) |
Gerstein HC. How common is postpartum thyroiditis? A meth-odologic overview
of the literature. Arch Intern Med 1990; 150: 1397-400. |
| (107) |
Othman S, Phillips DIW, Parkes AB, et al. A long-term follow-up of postpartum
thyroiditis. Clin Endocrinol (Oxf) 1990; 32: 559-64. |
| (108) |
Tachi J, Amino N, Tamaki H, Aozasa M, Iwatani Y, Miyai K. Long term follow-up
and HLA association in patients with postpartum hypothy-roidism. J Clin
Endocrinol Metab 1988; 66: 480-4. |
| (109) |
Mandel SJ, Brent GA, Larsen PR. Levothyroxine therapy in patients with
thyroid disease. Ann Intern Med 1993; 119: 492-502. |
| (110) |
Cooper DS, Halpern R, Wood LC, Levin AA, Ridgway EC. L-thy-roxine therapy
in subclinical hypothyroidism: a double-blind, placebo-con-trolled trial.
Ann Intern Med 1984; 101: 18-24. |
| (111) |
Nystrom E, Caidahl K, Fager G, Wikkelso C, Lundberg P-A, Lind-stedt G.
A double-blind cross-over 12-month study of L-thyroxine treat-ment of women
with "subclinical" hypothyroidism. Clin Endocrinol (Oxf)1988;
29: 63-75. |
| (112) |
Takasu N, Komiya I, Asawa T, Nagasawa Y, Yamada T. Test for recovery from
hypothyroidism during thyroxine therapy in Hashimoto's thyroid-itis. Lancet
1990; 336: 1084-6. |
| (113) |
Utiger RD. Vanishing hypothyroidism. N Engl J Med 1992; 326: 562-3. |
| (114) |
Hegedus L, Hansen JM, Feldt-Rasmussen U, Hansen BM, Hoier-Madsen M. Influence
of thyroxine treatment on thyroid size and anti-thyroid peroxidase antibodies
in Hashimoto's thyroiditis. Clin Endocrinol(Oxf) 1991; 35: 235-8. |
| (115) |
Kikuchi T, Yamaguchi Y, Kobayashi T, et al. Studies on thyroid vol-ume
during thyroid hormone therapy in patients with Hashimoto thyroid-itis.
In: Nagataki S, Mori T, Torizuka K, eds. 80 Years of Hashimoto dis-ease.
Amsterdam: Elsevier Science, 1993: 201-3. |
| (116) |
Chiovato L, Marcocci C, Mariotti S, Mori A, Pinchera A. L-thyroxine therapy
induces a fall of thyroid microsomal and thyroglobulin antibodies in idiopathic
myxedema and in hypothyroid, but not in euthyroid Ha-shimoto's thyroiditis.
J Endocrinol Invest 1986; 9: 299-305. |
| (117) |
Rieu M, Richard A, Rosilio M, et al. Effects of thyroid status on thy-roid
autoimmunity expression in euthyroid and hypothyroid patients with Hashimoto's
thyroiditis. Clin Endocrinol (Oxf) 1994; 40: 529-35. |